TUSSIBRON SCIR FL 190ML

TUSSIBRON

active ingredients

Tussibron 1% oxolamine citrate syrup 100 ml of syrup contain: Active ingredient: Oxolamine citrate 1 g. Excipients with known effects: sucrose, ethanol 96% (contained in alkermes aroma) and para-hydroxybenzoate methyl. Tussibron 100 mg oxolamine citrate tablets One tablet contains: Active ingredient: Oxolamine citrate 100 mg. Excipient with known effects: lactose. For the full list of excipients, see paragraph 6.1.

Excellent

Tussibron syrup: Sucrose, citric acid, alkermes aroma (ethanol 96%), para-hydroxybenzoate methyl, purified water. Tussibron tablets: Lactose, starch.

Therapeutic indications

Syntomatic treatment of cough of various nature.

Contraindications

- Hypersensitivity to components or other substances closely related to chemical.

Population

Adults: 15 ml syrup 4 times a day, or 1 or 2 tablets to swallow with a little water 3 times a day after meals. Children from 1 to 4 years: 5 ml syrup 4 times a day. Children from 4 years on: 10 ml syrup 4 times a day. Do not exceed the recommended doses.

Conservation

Store the container well closed.

Warnings

In patients under anticoagulant therapy it is recommended not to take Tussibron without consulting the doctor. Tussibron syrup contains sucrose: The product contains sugar. This is taken into account in diabetic patients and patients who follow hypocaloric dietary regimes. Patients with rare hereditary problems of fructose intolerance, glucose-galactosis mal absorption, or isolmaltase sucrasis failure, should not take this medicine. Tussibron syrup contains methyl para-hydroxybenzoate: It can cause allergic reaction (also delayed). Tussibron Sciroppo contains ethanol (contained in alkermes aroma): This medicine contains 0.2 mg of alcohol (ethanol) in each ml is equivalent to 0.02% w/v. The quantity in 60 ml of this medicine is equivalent to less than 1 ml of beer or 1 ml of wine. The small amount of alcohol in this medicine will not produce significant effects. Tussibron Compress contains lactose: Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose mal absorption, should not take this medicine. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor.

Interactions

Patients in treatment with anticoagulants should consult their physician before taking Tussibron.

Effects

Gastrointestinal disorders were rarely reported with nausea, vomiting and diarrhea. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

In case of accidental ingestion/intake of the medicine, immediately notify the doctor or contact the nearest hospital.

Tussibron can be used during pregnancy and nursing.

Source: Farmadati